International Trade Bulletin - Volume 1, Issue 17
Client Alert | 1 min read | 12.15.06
Inside this issue:
- TRENDS IN TRADE REMEDIES IN THE SPOTLIGHT
- EUROPE IN THE SPOTLIGHT
- MARKET ACCESS: After Doha: Practical Approaches for Cutting the Costs of Trade - Making the Most of FTAs
- COUNTERVAILING: Commerce Initiates First Countervailing Duty Investigation Involving Chinese Subsidies in 15 Years
- SANCTIONS: Change expected soon in scope of US sanctions on North Korea
- SANCTIONS: Recent Changes in U.S. Policy Expand Business Opportunities in Sudan
- U.S. LEGISLATION: Hours before the close of the 109th Session of Congress, the House and Senate approved a package of trade legislation with wide-ranging implications for the international business community
- AVIATION: U.S. DOT Decision to Scuttle Foreign Control Rule Leaves U.S.-EU Open Skies Accord in Doubt
- REGULATORY: REACH Regulation on track for adoption by EU Council
Contacts
Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 3 min read | 04.17.26
Client Alert | 2 min read | 04.16.26
Client Alert | 4 min read | 04.16.26
ROI Tracking as Mens Rea? Novartis Ruling Reframes AKS Pleading Risk
